WAYNE, Pa.--(BUSINESS WIRE)--Sep. 13, 2018--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
technologies for critical care and surgery, today announced that during
the ERC Congress, it will focus on the Arrow® EZ-IO®
Intraosseous Access System and on the campaign “What could 10 seconds to
vascular access mean to your cardiac arrest patient?”
Cardiac Arrest is one of the leading causes of mortality with an
estimated 10% survival rate.1 2
Prompt treatment is essential for all cardiac arrest patients, whether a
patient suffers an in-hospital cardiac arrest (IHCA) or an
out-of-hospital cardiac arrest (OHCA). Studies have found an incidence
rate of 84 OHCA per 100,000 population 2 and between
1.51-2.85 IHCA per 1.000 hospital patient admissions.3,4 The
incidence of cardiac arrest is a major health problem within Europe &
the United States.
When a cardiac arrest occurs, rapid delivery of fluids and medication is
key to treatment. Clinicians need fast methods of establishing vascular
access, and IV access may be difficult or impossible due to
cardiovascular collapse and environmental challenges.
The Arrow® EZ-IO® Intraosseous Vascular Access
System from Teleflex is a fast, safe and effective solution in emergency
situations 5,6,7,8. The EZ-IO® System is indicated
anytime vascular access is difficult to obtain in emergent, urgent, or
medically necessary cases for up to 72 hours within Europe. The EZ-IO
System is a difficult vascular access option that provides peripheral
venous access with central venous catheter performance.7, 9, 10
While ERC is taking place, Teleflex will also host several educational
sessions that will be run by the Teleflex Clinical & Medical Affairs
team. These sessions take place on Friday 21st and Saturday 22nd.
Some of the planned Teleflex Education programs include – “Humeral IO
Masterclass”; “IO Emergency Scenario”; “Pediatric IO Masterclass”; and
“Using IO in Resuscitation”.
Moreover, in collaboration with the Italian Red Cross and European
Resuscitation Council, Teleflex will also host an innovative Helicopter
Resuscitation Simulation Workshop titled “Helicopter Resuscitation:
Let's remember the airway & vascular access”. Healthcare professionals
attending the ERC Congress can easily book his/her place at http://TeleflexCMA.formstack.com/forms/helicopter.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply
purpose-driven innovation – a relentless pursuit of identifying unmet
clinical needs – to benefit patients and healthcare providers. Our
portfolio is diverse, with solutions in the fields of vascular and
interventional access, surgical, anesthesia, cardiac care, urology,
emergency medicine and respiratory care. Teleflex employees worldwide
are united in the understanding that what we do every day makes a
difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®,
Rüsch® and Weck® – trusted brands united by a common sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
|
|
|
1.
|
|
|
Mozaffarian D, Benjamin EJ, Go AS, et al: on behalf of the
American Heart Association Statistics Committee and Stroke
Statistics Subcommittee. Heart disease and stroke statistics—2015
update: a report from the American Heart Association. Circulation.
2015;131:e29–e322. DOI: 10.1161/CIR.0000000000000152.
|
|
2.
|
|
|
EuReCa ONE 27 Nations, ONE Europe, ONE Registry: A prospective one
month analysis of out-of-hospital cardiac arrest outcomes in 27
countries in Europe, Volume 105, August 2016, Pages 188-195
|
|
3.
|
|
|
Incidence and outcome of in-hospital cardiac arrest in Italy: a
multicentre observational study in the Piedmont Region,
Resuscitation [24 Jun 2017, 119:48-55]
|
|
4.
|
|
|
Public Report Cards for In-Hospital Cardiac Arrest: Empowering the
Public With Location-Specific Data, Circulation. Author manuscript;
available in PMC 2016 Apr 21
|
|
5.
|
|
|
Davidoff J, Fowler R, Gordon D, Klein G, Kovar J, Lozano M, Potkya
J, Racht E, Saussy J, Swanson E, Yamada R, Miller L. Clinical
evaluation of a novel intraosseous device for adults: prospective,
250-patient, multi-center trial. JEMS 2005;30(10):s20-3. Research
sponsored by Teleflex Incorporated.
|
|
6.
|
|
|
Montez D, Puga T, Miller LJ, et al. Intraosseous Infusions from the
Proximal Humerus Reach the Heart in Less Than 3 Seconds in Human
Volunteers. Annals of Emergency Medicine 2015;66(4S):S47. Research
sponsored by Teleflex Incorporated.
|
|
7.
|
|
|
Cooper BR, Mahoney PF, Hodgetts TJ, Mellor A. Intra-osseous access
(EZ-IO®) for resuscitation: UK military combat experience. J R
Army Med Corps. 2007;153(4):314-31 *, **
|
|
8.
|
|
|
Teleflex Internal Data on file 2018
|
|
9.
|
|
|
Hoskins SL, Nascimento P Jr., Lima RM, Espana-Tenorio, JM, Kramer
GC. Pharmacokinetics of intraosseous and central venous drug
delivery during cardiopulmonary resuscitation. Resuscitation 2011;
doi:10.1016/j.resuscitation.2011.07.041. Research sponsored by
Teleflex Incorporated. (preclinical study) *, **
|
|
10.
|
|
|
Hoskins SL, Zachariah BS, Copper N, Kramer GC. Comparison of
intraosseous proximal humerus and sternal routes for drug delivery
during CPR. Circulation 2007; 116:II_993. Research sponsored by
Teleflex Incorporated. (preclinical study) *, **
|
|
*Compared to single lumen Central Venous Catheters (CVCs).
|
|
**Based on Adult Proximal Humerus EZ-IO® insertion data.
|
|
|

View source version on businesswire.com: https://www.businesswire.com/news/home/20180913005092/en/
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836